Alantolactone and ZnO Nanoparticles Induce Apoptosis Activity of Cisplatin in an Ovarian Cancer Cell Line (SKOV3)

Overview

Journal Res Pharm Sci

Specialty Chemistry

Date 2022 May 9

PMID 35531132

Authors

Shahriar Alipour

Ghader Babaei

Shiva Gholizadeh-Ghaleh Aziz

Somayeh Abolhasani

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Ovarian cancer is one of the leading causes of cancer mortality in women. Despite the increase in cases of this cancer, the current therapeutic strategy is not effective. This study aimed to investigate the effect of cisplatin (Cis) with alantolactone (ALT) and ZnO nanoparticles (ZnONPs) in inducing apoptosis in SKOV3 ovarian cancer cells line.

Experimental Approach: To evaluate the viability of SKOV3 cells and determine the IC of Cis, ALT, and ZnONPs, MTT assay was used. Real-time PCR and western blotting were used to evaluate the expression levels of genes (XIAP, cyclin D1, Bcl-2, Bax, and MDM2) and proteins (XIAP, cyclin D1, Bcl-2, Bax), respectively. Also, cellular ROS levels were assessed by fluorimetry.

Findings / Results: Our results showed that ALT and ZnONPs significantly increased the response to Cis in SKOV3 cells compared to the control and this response is remarkably increased in the triple combination (ALT-Cis-ZnONPs). The expression of XIAP, cyclin D1, and Bcl-2 genes and proteins in the groups treated with ALT, Cis, and ZnONPs as a single agent, double and triple combination were significantly reduced compared to the control, while Bax was generally shown an increase. Also, the level of intracellular ROS is higher in the treatment groups than in the control group and the highest increase was observed in the triple combination.

Conclusion And Implications: Taken together, our data demonstrated the potential therapeutic approach of using ALT and ZnONPs that may enhance the apoptotic effects of Cis on the SKOV3 cells.

Citing Articles

Biosynthesis and health promoting traits of green synthesized cobalt oxide nanoparticles.

Moawad R, Abdallah Y, Mohany M, Al-Rejaie S, Djurasevic S, Ramadan M Sci Rep. 2025; 15(1):727.

PMID: 39753648 PMC: 11698730. DOI: 10.1038/s41598-024-82679-y.

Synthesis of F127-GA@ZnO nanogel as a cisplatin drug delivery pH-sensitive system.

Son N, Thanh V, Huong N RSC Adv. 2024; 14(47):35005-35020.

PMID: 39497764 PMC: 11533520. DOI: 10.1039/d4ra06514j.

Sesquiterpene lactones as emerging biomolecules to cease cancer by targeting apoptosis.

Hsu C, Rajabi S, Hamzeloo-Moghadam M, Kumar A, Maresca M, Ghildiyal P Front Pharmacol. 2024; 15:1371002.

PMID: 38529189 PMC: 10961375. DOI: 10.3389/fphar.2024.1371002.

Alantolactone triggers oxeiptosis in human ovarian cancer cells via Nrf2 signaling pathway.

Nasirzadeh M, Atari Hajipirloo S, Gholizadeh-Ghaleh Aziz S, Rasmi Y, Babaei G, Alipour S Biochem Biophys Rep. 2023; 35:101537.

PMID: 37712005 PMC: 10497985. DOI: 10.1016/j.bbrep.2023.101537.

Zinc Oxide Nanoparticles and Cancer Chemotherapy: Helpful Tools for Enhancing Chemo-sensitivity and Reducing Side Effects?.

Vaghari-Tabari M, Jafari-Gharabaghlou D, Mohammadi M, Hashemzadeh M Biol Trace Elem Res. 2023; 202(5):1878-1900.

PMID: 37639166 DOI: 10.1007/s12011-023-03803-z.

References

Khan M, Yi F, Rasul A, Li T, Wang N, Gao H . Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction. IUBMB Life. 2012; 64(9):783-94. DOI: 10.1002/iub.1068. View

Wahab R, Dwivedi S, Umar A, Singh S, Hwang I, Shin H . ZnO nanoparticles induce oxidative stress in Cloudman S91 melanoma cancer cells. J Biomed Nanotechnol. 2013; 9(3):441-9. DOI: 10.1166/jbn.2013.1593. View

Hu Z, Cai M, Zhang Y, Tao L, Guo R . miR-29c-3p inhibits autophagy and cisplatin resistance in ovarian cancer by regulating FOXP1/ATG14 pathway. Cell Cycle. 2019; 19(2):193-206. PMC: 6961660. DOI: 10.1080/15384101.2019.1704537. View

Bai D, Zhang X, Zhang G, Huang Y, Gurunathan S . Zinc oxide nanoparticles induce apoptosis and autophagy in human ovarian cancer cells. Int J Nanomedicine. 2017; 12:6521-6535. PMC: 5592910. DOI: 10.2147/IJN.S140071. View

Kenzaoui B, Chapuis Bernasconi C, Guney-Ayra S, Juillerat-Jeanneret L . Induction of oxidative stress, lysosome activation and autophagy by nanoparticles in human brain-derived endothelial cells. Biochem J. 2011; 441(3):813-21. DOI: 10.1042/BJ20111252. View

Kreuger M, Grootjans S, Biavatti M, Vandenabeele P, DHerde K . Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide. Anticancer Drugs. 2012; 23(9):883-96. DOI: 10.1097/CAD.0b013e328356cad9. View

Bisht G, Rayamajhi S . ZnO Nanoparticles: A Promising Anticancer Agent. Nanobiomedicine (Rij). 2018; 3:9. PMC: 5998263. DOI: 10.5772/63437. View

Abbaspour J, Ehsanpour A, Aghaei M, Ghanadian M . Sesquiterpene lactones from shoot culture of with cytotoxicity against prostate and breast cancer cells. Res Pharm Sci. 2019; 14(4):329-334. PMC: 6714112. DOI: 10.4103/1735-5362.263557. View

Rasul A, Khan M, Ali M, Li J, Li X . Targeting apoptosis pathways in cancer with alantolactone and isoalantolactone. ScientificWorldJournal. 2013; 2013:248532. PMC: 3826378. DOI: 10.1155/2013/248532. View

10.

Padmanabhan A, Kaushik M, Niranjan R, Richards J, Ebright B, Venkatasubbu G . Zinc Oxide nanoparticles induce oxidative and proteotoxic stress in ovarian cancer cells and trigger apoptosis Independent of p53-mutation status. Appl Surf Sci. 2020; 487:807-818. PMC: 7009796. DOI: 10.1016/j.apsusc.2019.05.099. View

11.

Jiang Y, Xu H, Wang J . Alantolactone induces apoptosis of human cervical cancer cells via reactive oxygen species generation, glutathione depletion and inhibition of the Bcl-2/Bax signaling pathway. Oncol Lett. 2016; 11(6):4203-4207. PMC: 4888199. DOI: 10.3892/ol.2016.4511. View

12.

Tanino R, Amano Y, Tong X, Sun R, Tsubata Y, Harada M . Anticancer Activity of ZnO Nanoparticles against Human Small-Cell Lung Cancer in an Orthotopic Mouse Model. Mol Cancer Ther. 2019; 19(2):502-512. DOI: 10.1158/1535-7163.MCT-19-0018. View

13.

Zhang X, Zhang H . Alantolactone induces gastric cancer BGC-823 cell apoptosis by regulating reactive oxygen species generation and the AKT signaling pathway. Oncol Lett. 2019; 17(6):4795-4802. PMC: 6507453. DOI: 10.3892/ol.2019.10172. View

14.

Guo X, Fang Z, Zhang M, Yang D, Wang S, Liu K . A Co-Delivery System of Curcumin and p53 for Enhancing the Sensitivity of Drug-Resistant Ovarian Cancer Cells to Cisplatin. Molecules. 2020; 25(11). PMC: 7321199. DOI: 10.3390/molecules25112621. View

15.

Puvvada N, Rajput S, Prashanth Kumar B, Sarkar S, Konar S, Brunt K . Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression. Sci Rep. 2015; 5:11760. PMC: 4491843. DOI: 10.1038/srep11760. View

16.

Yu L, Chen M, Zhang R, Jin Z . Inhibition of cancer cell growth in gemcitabine-resistant pancreatic carcinoma by mangiferin phytochemical involves induction of autophagy, endogenous ROS production, cell cycle disruption, mitochondrial mediated apoptosis and suppression of cancer.... J BUON. 2019; 24(4):1581-1586. View

17.

Jafari S, Nazri A, Shabani M, Zargar Balajam N, Aghaei M . Galectin-9 induces apoptosis in OVCAR-3 ovarian cancer cell through mitochondrial pathway. Res Pharm Sci. 2019; 13(6):557-565. PMC: 6288986. DOI: 10.4103/1735-5362.245967. View

18.

Ding Y, Wang H, Niu J, Luo M, Gou Y, Miao L . Induction of ROS Overload by Alantolactone Prompts Oxidative DNA Damage and Apoptosis in Colorectal Cancer Cells. Int J Mol Sci. 2016; 17(4):558. PMC: 4849014. DOI: 10.3390/ijms17040558. View

19.

Khan M, Li T, Ahmad Khan M, Rasul A, Nawaz F, Sun M . Alantolactone induces apoptosis in HepG2 cells through GSH depletion, inhibition of STAT3 activation, and mitochondrial dysfunction. Biomed Res Int. 2013; 2013:719858. PMC: 3591150. DOI: 10.1155/2013/719858. View

20.

Babaei G, Ansari M, Gholizadeh-Ghaleh Aziz S, Rajabi Bazl M . Alantolactone inhibits stem-like cell phenotype, chemoresistance and metastasis in PC3 cells through STAT3 signaling pathway. Res Pharm Sci. 2021; 15(6):551-562. PMC: 8020850. DOI: 10.4103/1735-5362.301340. View